Cite
MLA Citation
M. Lind et al.. “Five-year outcomes from the randomized, phase 3 trials CheckMate 017/057: nivolumab vs docetaxel in previously treated NSCLC.” Lung cancer, vol. 139, n.d., pp. S49–S50. http://access.bl.uk/ark:/81055/vdc_100099354041.0x00004d